The Science

THE SCIENCE BEHIND
PHYSIOLOGIC INSULIN RESENSITIZATION

Diabetes Relief Care at Vijuvia Life Centers equips physicians to provide our unique and groundbreaking patented infusion treatment called Physiologic Insulin Resensitization where insulin is administered as a hormone rather than a drug; addressing the primary cause of Diabetes, metabolic failure. By utilizing insulin in a manner that bio-mimics normal physiology, we are able to reduce insulin resistance which helps blood sugar more readily enter each cell and be converted into energy.

Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. Thus, our approach not only stabilizes but in many instances has reversed complications of diabetes and other metabolic disorders.

Contact

13940 US Hwy 441,

Suite 703, Ladylake, FL 32159

physiologic Administration

By precision administrating insulin in a manner that bio-mimics normal physiology, we are able to up-regulate insulin receptor activity and reduce insulin resistance.

Treatment

The treatment is designed to reduce insulin resistance, which is the primary cause of type 2 diabetes and other metabolic disorders.

Infusion Treatment

The treatment is designed to reduce insulin resistance, which is the primary cause of type 2 diabetes and other metabolic disorders.

 

  • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
  • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
  • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
  • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
  • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
  • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
    SYMPTOM SUPPRESSION VS. SYMPTOM ELIMINATION

    Insulin has been used since 1922 as a “drug” to suppress symptoms of high blood sugar after they start. Restor Metabolix uses insulin intravenously as a “hormone communicator” in a more physiologically identical way to the body’s manner of maintaining an optimized metabolism.

     

    • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
    • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
    • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
    • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
    • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
    • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
      INSULIN AS A HORMONE VS. A DRUG

      What makes this modality unique is using insulin as a hormone rather than a drug.

       

      • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
      • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
      • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
      • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
      • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
      • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
        CELLULAR HEALTH

        By increasing cellular energy, Physiologic Insulin Resensitization is designed to repair and regenerate the body’s cells, peripherally at first, and then through repeated treatment sessions, cellular restoration progresses to the organs, helping the body to naturally return to its more normal physiologic state. Thus, the treatment has not only stabilized, but in many instances has reversed, complications of diabetes and other metabolic disorders.

         

        • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
        • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
        • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
        • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
        • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
        • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
          RESTORING, REPAIRING, REGENERATING, BUT NOT A CURE

          Unfortunately, metabolic impairment is a chronic disease. If patients stop therapy, the improvements experienced from these treatments will diminish over time.

           

          • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
          • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
          • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
          • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
          • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
          • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.
            DATA COLLECTION AND REPEATABLE OUTCOMES

            Diabetes Relief Center is actively engaged in gathering clinical data in multi-centered, case-controlled, prospective studies, in order to better inform physicians everywhere of this process of physiologic insulin administration and its amazing reductions in diabetic complications.

            We are looking for clinical partners to help us in confronting the diabetes epidemic and improving patient outcomes using this hormonal, physiologic insulin approach.

            Our Patients Report

            • Improved neuropathy 95% 95%
            • Report improvement in at least one diabetic complication 76% 76%
            • Report HbA1c reduction 63% 63%
            • Reduced diabetic medications 41% 41%

            Want More Information?